13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
A subcontractor has liened the property although the owner has paid in full for its work. The genera...
Read More >
On January 13, 2020, the U.S. Department of Treasury published final regulations relating to the Com...
Read More >
In a recent decision, a Pennsylvania county court ruled that the state’s Medical Marijuana Act crea...
Read More >
The long-awaited application of the European Union (EU) Regulation on a framework for the screening ...
Read More >
401(k) Plan Sponsors Maybe Cutting Their Nose To Spite Their Face. It's an absolute mistake. I onc...
Read More >
On October 28, 2019, the Ninth Circuit, following in the footsteps of the D.C. Circuit and the Secon...
Read More >